New York A06518 mandates counselling for patients about opioid addiction risks before prescriptions and at refills.

New York A06518 amends the public health law to require practitioners to counsel patients about the potential addictive properties of opioids before prescribing them. This counselling must occur at the initial prescription and every subsequent renewal. Pharmacists must also counsel patients about these risks when filling the initial prescription and at each refill. The counselling includes information on the risks of dependence, misuse, overdose, pain management, side effects, treatment goals, and naloxone use in case of accidental overdose.

New York A06518 mandates counselling for patients about opioid addiction risks before prescriptions and at refills.

New York A06518 amends the public health law to require practitioners to counsel patients about the potential addictive properties of opioids before prescribing them. This counselling must occur at the initial prescription and every subsequent renewal. Pharmacists must also counsel patients about these risks when filling the initial prescription and at each refill. The counselling includes information on the risks of dependence, misuse, overdose, pain management, side effects, treatment goals, and naloxone use in case of accidental overdose.